RA Capital Management bought 536,426 shares at blended $0.91 across 3 transactions; now holds 6.24M shares (+9.4%).
RA Capital Management, listed as a Director, executed 3 separate purchases totaling 536,426 shares for $487,187.92 at a blended average price of $0.91 on May 12-14, 2025, increasing its position from 5.70M to 6.24M shares. The timing coincides with a 30-day stock price gain of +28.3%, though the stock remains -82.2% from its 52-week high of $5.57 and trades at current price $0.99. The company is unprofitable with net income of $-18,089,000.00 and a market cap of $44,424,909.54, indicating a cash-constrained biotech profile. Across RA Capital's cross-ticker open-market history, 18 prior buys averaged +20.4% return over 30 days (69.23% win rate), suggesting a track record of timely buy decisions, though historical performance does not guarantee outcomes at this particular ticker.